Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100047419Phase 4Recruiting
Phase 4, randomised trial of esketamine in postoperative pain and postpartum depression (PPD) (2 arms), sponsored by Hunan University of Medicine General Hospital. Primary endpoints: Vital signs, Analgesia score and 3 more. Started Apr 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100047419.